title: Relocating rheumatology patients to a new infusion center at Duke: a case study.
abstract: This case study concerns relocating rheumatology patients at Duke University Medical Center to a new infusion center located in a physician based treatment setting. The case study follows the managerial decision-making process as it describes how the infusion center treatment site was chosen, how it was set up, how it functions, and what benefits to patient care it provides. A successful site-of-car relocation requires strong managers who are able to weigh objectively alternative courses of action. Moreover, the project champion must be able to distinguish key factors inside and outside the organization and chart the project's course accordingly.
authors.affiliation: Resource Group Ltd., Pickton, Tex, USA.
authors.forename: Judith J
authors.initials: JJ
authors.lastname: Baker
authors.forename: Todd M
authors.initials: TM
authors.lastname: Leovic
authors.forename: Carolyn A
authors.initials: CA
authors.lastname: O'Connor
authors.forename: Christine A
authors.initials: CA
authors.lastname: Pierce
mesh_terms: D000046:Academic Medical Centers / Q000458:organization & administration*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy; D003659:Decision Making, Organizational; D005762:Gastroenterology / Q000458:organization & administration; D005765:Gastrointestinal Agents / Q000008:administration & dosage; D018578:Hospital-Physician Relations; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D009657:North Carolina; D019982:Organizational Case Studies; D010044:Outpatient Clinics, Hospital / Q000458:organization & administration*; D010360:Patient Transfer; D012219:Rheumatology / Q000458:organization & administration*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D005765:Gastrointestinal Agents; D000069285:Infliximab